Stephen Duricko, a founding partner of topical pain relief manufacturer Topical BioMedics Inc., passed away at age 74. The company said Tuesday that Duricko died on Oct. 21 at his residence in Red Hook, N.Y.
TheraPearl has landed retail distribution at select Safeway food and drug stores, with all 1,200 of the supermarket chain’s stores slated to carry its hot/cold therapy offerings by December.
UCB has entered an agreement to sell its Kremers Urban U.S. specialty generic drug business to private equity firms Advent International and Avista Capital Partners for $1.525 billion.
Ermis Labs reports that its new medicated skin care bars are being applauded by dermatologists. The company said that the products drew an overwhelmingly positive response at the American Academy of Dermatology Summer Conference in Chicago.
Carma Laboratories Inc. is bringing a fresh look to its Carmex skin care brand on shelves at chain drug stores and other retail outlets.
O’Connor Companies LLC has expanded retail distribution for GoGargle!, an effervescent salt gargle designed to provide a more refreshing option to relieve dry, irritated throats.
As part of its strategy to sharpen its focus on core brands, Procter & Gamble Co. plans to spin off the Duracell battery business. P&G announced the plan Friday in reporting fiscal 2015 first-quarter earnings. The consumer products giant said that it’s exiting the battery business in two steps.
Lay’s Kettle Cooked Wasabi Ginger flavored potato chips emerged as the winner of this year’s Lay’s "Do Us A Flavor" contest by Frito-Lay.
Purdue Pharma is working with the American Pharmacists Association (APhA) to distribute a series of resources that address pharmacist knowledge gaps with Butrans, the drug company’s Schedule III extended-release transdermal opioid pain medication.
General Mills Inc. has closed its acquisition of natural food company Annie’s Inc. General Mills said Tuesday that it completed its tender offer to buy Annie’s for $46 per share, or about $820 million. The deal was announced early last month.
L’Oreal USA has entered into an agreement to buy natural beauty products maker Carol’s Daughter. Financial terms of the transaction weren’t disclosed. The agreement is pending regulatory approval as well as other customary closing conditions.
Rob Meriweather has been promoted to vice president of sales at H.D. Smith.
To help alleviate the discomfort and pain of children with eczema, Topical BioMedics Inc. has launched program in which it will send parents a free tube of its Topricin Junior for Children topical analgesic.
Takeda Pharmaceuticals USA Inc. and Orexigen Therapeutics Inc. have shipped Contrave extended-release tablets, a weight management medication for obese adults, to U.S. pharmacies.
Horizon Pharma plc has acquired the U.S. rights to arthritis treatment Pennsaid 2% from Nuvo Research Inc.
Cosmederm Bioscience Inc.’s TriCalm Anti-Itch Hydrogel has been granted the National Eczema Association (NEA) Seal of Acceptance. The specialty pharmaceutical company said the seal recognizes TriCalm as a product appropriate for the care of itching related to eczema or sensitive skin.
